<?xml version="1.0" encoding="UTF-8"?>
<p>Intensive chemotherapy in cancer patients can cause neutropenic fever and infection, which delays chemotherapy cycles and increases mortality and morbidity of chemotherapy-treated patients.
 <xref rid="b1-dddt-12-2381" ref-type="bibr">1</xref> Granulocyte-colony stimulating factors (G-CSFs), which stimulate and control the proliferation and differentiation of leukocytes, neutrophils, and macrophages, help prevent bone marrow suppression and reduce the incidence of neutropenic fever.
 <xref rid="b2-dddt-12-2381" ref-type="bibr">2</xref>,
 <xref rid="b3-dddt-12-2381" ref-type="bibr">3</xref> In addition, use of G-CSFs on febrile neutropenia is related to reduced infection-related death and all-cause mortality.
 <xref rid="b4-dddt-12-2381" ref-type="bibr">4</xref>,
 <xref rid="b5-dddt-12-2381" ref-type="bibr">5</xref> Thus, prophylactic use of G-CSFs in patients at high risk (&gt;20%) of fever and neutropenia is recommended.
 <xref rid="b2-dddt-12-2381" ref-type="bibr">2</xref>
</p>
